News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pernix Therapeutics, Inc. (PTX) to Present at the Canaccord Genuity 32nd Annual Global Growth Conference


8/9/2012 10:37:41 AM

THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX), a specialty pharmaceutical company, today announced that Cooper Collins, President and Chief Executive Officer, will present at the Canaccord Genuity 32nd Annual Global Growth Conference on Thursday, August 16, 2012 at 8:30 a.m. EDT. The conference will be held at the InterContinental Boston in Boston, MA.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES